Diane J Mathis
- Harvard Medical School · Pathology (NIH department code)
- Harvard Medical School · Microbiology & Immunology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #14,726
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6133591Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pathology
- Microbiology & Immunology
NIH Funding · FY2026
Linked Award Amount
$1.4M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#14,726
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Diane J Mathis as a PI. Multi-PI records show the full award amount for context.
- 5R01AI088204-13R01Contact PIThe molecular mechanism of AireHarvard Medical School · Pathology (NIH department code)$506.8Kaward amount
- 5R01DK092541-16R01Contact PIAdipose-tissue Tregs: important players in immunological control of metabolismHarvard Medical School · Pathology (NIH department code)$423.8Kaward amount
- 5R01DK060027-25R01Contact PIAire, a zinc-finger protein that controls autoimmunityHarvard Medical School · Microbiology & Immunology (NIH department code)$423.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Diane J Mathis as a PI.
FY2026 award administered by Harvard Medical School (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardHarvard Medical School
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7249
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder